ISO/IEC 표준전문가 역량 강화 (02.01-02)' 무료 교육 선착순 모집 안내 (0)	2024.01.24
[KTR] 클린뷰티 화장품 관련 장비 실습/실무, ESG 보고서 작성 실습 무료 교육 진행 (재직자 대상) (0)	2023.11.29
[한국화학융합시험연구원]탄소저감 및 탄소 배출량 산정 무료 세미나 진행(11/15) (0)	2023.11.29
[KTR]친환경 패키징, 지속가능한 화이트바이오 제품 전략 "무료 교육" 안내 (재직자 대상) (0)	2023.11.29
[KTR] 지속가능한 화이트바이오 제품 전략, 사례, 특허 관한 무료 교육!(재직자 대상) (0)	2023.10.06

구분	보고서 (영문)
제약/바이오/임 상시험	Takeda’s Eohilia to Compete Sanofi’s Dupixent in Eosinophilic Esophagitis Treatment
	eConsent: The Overlooked Patient-Centric Tool
	The Magrolimab Trial Halt Highlights the Uncertainties in Anti-CD47 Immunotherapy
	The Tiny Pills That May Send Shockwaves Across Immunology
	Cell and Gene Therapy Landscape in the US
	Another Setback for Minerva’s Schizophrenia Treatment Roluperidone
	APAC Led in Trials for 2023, with the Majority in Phase II
	Oncology Emerges as Dominant Therapy Area for CRISPR Technology
	Allecra’s EXBLIFEP Provides Valuable New Weapon to Tackle ESBL Mediated AMR
	AbbVie and Genmab’s Epkinly Joins BiTE Competition in Follicular Lymphoma
질환별	Comorbidities Associated with ADHD Present an Opportunity for Pipeline Products to Capture the Market
	Female Sexual Dysfunction: Competitive Landscape
	Shifting the Paradigm – Novel Approaches to Amyotrophic Lateral Sclerosis Therapy
	Cell & Gene Therapies in Hemophilia A & B
	Shifting Patterns in Cervical Cancer Cases in Women in Their 30s and 40s
컨퍼런스/심포 지엄/학회/기타	IO360: First Allogeneic Dual CAR T-Cell Therapy Shows Promise in B Cell Non-Hodgkin Lymphom
	Biotech Funding Optimism Rises as 44% Predict Recovery in 2024
	Market Cap Upturn for Top 20 Biopharma Companies with Obesity Drug Successes in 2023
	AD/PD 2024: The Role of Blood-Based Biomarkers in Alzheimer’s Disease
	AD/PD 2024: Promising Data for Monitoring Speech Deficits in Early Parkinson’s

[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 (0)	2024.03.15
[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 (0)	2024.03.15
[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서 (0)	2024.03.15
[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 1.22.(월) (0)	2024.01.24
[KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 (0)	2024.01.08

구분	보고서 (영문)
제약/바이오/임상시험	EMA CHMP Decision for Nezglyal Recommends Refusal of Marketing Authorization
	Novartis Will See Modest Boost to Blood Cancer Portfolio with MorphoSys Acquisition
	Epetraborole Phase III Enrollment Pause Sets Back NTM Late-Stage Pipeline
	Beacon Therapeutics Unveils Promising Interim Results for Gene Therapy AGTC-501
	ViiV Healthcare and GSK’s Cabenuva Could Reduce Poor Treatment Adherence in HIV
	Biogen Discontinues Aduhelm to Focus on Leqembi for Alzheimer’s Disease
질환별	2023–24 Seasonal Flu Activity Remains Elevated
	Non-Small Cell Lung Cancer (NSCLC): Epidemiology Forecast to 2032
	Will Smart Technology Revolutionize Drug Delivery for Ulcerative Colitis Patients?
	Central Nervous System Takes the Lead in Global Drug Withdrawals
	Burden of Dental Diseases Rises Sharply in the UK
컨퍼런스/심포지엄/학회/기타	Conference Organizing Tool - ADPD 2024
컨퍼런스/심포지엄/학회/기타	Conference Organizing Tool – European Lupus Meeting (ELM) 2024 - Interim

toucrew

분류 전체보기